Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma

MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2

(2017) Peilong Li et al.   MOLECULAR CANCER THERAPEUTICS

Survival in glioblastoma: a review on the impact of treatment modalities

(2016) P. D. Delgado-López et al.   Clinical & Translational Oncology

High expression of long non-coding RNAAFAP1-AS1predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

(2016) Xi-Lei Zhou et al.   MOLECULAR CARCINOGENESIS

MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma

(2016) Tian Tian et al.   Oncotarget

HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2

(2016) Mengying Wu et al.   Scientific Reports

TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells

(2015) Tian Tian et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line

(2015) Paweena Chunharojrith et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1

(2015) I Vassallo et al.   ONCOGENE

Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma

(2015) Kang-xiao Ma et al.   TUMOR BIOLOGY

A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma

(2015) Chun-Lin Zhang et al.   TUMOR BIOLOGY

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

(2015) Yosuke Konno et al.   Oncotarget

Tumor-suppressivemicroRNA-218inhibits cancer cell migration and invasion via targeting ofLASP1in prostate cancer

(2014) Rika Nishikawa et al.   CANCER SCIENCE

TGF- -Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12

(2014) Y. Fan et al.   CLINICAL CANCER RESEARCH

Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer

(2014) Xiang-hua Liu et al.   Molecular Cancer

Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O 6 -methylguanine DNA methyltransferase promoter methylation via c-Myc signaling

(2013) Ilya V. Pyko et al.   CARCINOGENESIS

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma

(2013) NORIKO YAMAMOTO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Long Noncoding RNA MALAT-1 is a New Potential Therapeutic Target for Castration Resistant Prostate Cancer

(2013) Shancheng Ren et al.   JOURNAL OF UROLOGY

Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB

(2013) Vidisha Tripathi et al.   PLoS Genetics

The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells

(2012) T. Gutschner et al.   CANCER RESEARCH

Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

(2011) E. M. Goellner et al.   CANCER RESEARCH

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

(2011) James W.F. Catto et al.   EUROPEAN UROLOGY

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

(2010) Jin-Hyeok Hwang et al.   PLoS One

Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation

(2010) Dan Yan et al.   PLoS One

A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells

(2009) Meryem Bektas et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

(2009) S. Yip et al.   CLINICAL CANCER RESEARCH

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

(2009) K-H Lee et al.   ONCOGENE